Celgene places $1bn bet on biotech Juno

Investment is close to 100% premium to Monday’s close

Warning on threat to Greek drug supplies

Fears grow that euro exit would disrupt supplies

Samsung: similar outcome

A heady valuation for its biosimilars business may be intended to sweeten merger terms

786 Pharmacy Afghanistan

InFrontier takes stake in Afghan pharmacy

UK group says deal shows the country is opening to business

Eli Lilly and Immunocore to collaborate

US and UK pharma groups aim to develop combination cancer therapies

Samsung Bioepis eyes Nasdaq listing

South Korean company targets valuation of at least $8bn

DNA double helix. High resolution 3d rendering.

Geneticists’ quest for crisper prose

Deleting disease at genome level calls for contemplation by lawyers, philosophers and the public

Teijin spooks mosquitoes and woos buyers

Fear of dengue fever in Japan lift sales of wonder fabric

African trials fuel malaria vaccine hopes

Equatorial Guinea hosts tests that hold promise of end to disease

UN warns against complacency over Aids

Number of cases of the disease rising in some countries

Johnson floats £10bn London biotech fund

Mayor tackles complaints of lack of risk capital

Google tests medical tracking device

Wrist-worn sensors to produce continual electrocardiogram

Viehbacher to head $2bn Bertarelli fund

Former Sanofi chief says he is cautious of soaring valuations

Peanut allergy trials raise hopes

Treatments of life-threatening reaction move closer to approval

CVC and Temasek team up for Alvogen deal

Investors buy majority stake in US-based group, valuing it at $2bn

Allergan injects $2.1bn into Kybella drug

Botox maker aims to see off rivals with double-chin treatment

Saracen becomes upbeat about US stocks

Managers find opportunities in the banking and mining sectors

Indian pharma pollution is a bitter pill

Concern over environmental damage caused by outsourcing

Toyota manager arrested over painkillers

Communications chief held after prescription drug seizure

Frozen forehead meets double chin

Botox owner Allergan to pay $2bn for biotech group Kythera

EDITOR’S CHOICE

Special report

insulin vials ©Jacob Ehrbahn Combating Diabetes

Special report

An elderly man uses a magnifier to see the descriptions on a pack of medicine at a pharmacy in Dandong, Liaoning province March 30, 2011 ©Jacky Chen/Reuter Health: Emerging Markets

COMPANIES NEWS ON TWITTER

More FT Twitter accounts
SHARE THIS QUOTE